Clarivate (NYSE:CLVT) Trading 7.2% Higher – Here’s Why

Clarivate PLC (NYSE:CLVT)’s share price was up 7.2% on Monday . The company traded as high as $2.56 and last traded at $2.5950. Approximately 408,122 shares changed hands during mid-day trading, a decline of 94% from the average daily volume of 6,594,377 shares. The stock had previously closed at $2.42.

Analysts Set New Price Targets

Several equities research analysts have commented on the company. Wall Street Zen upgraded Clarivate from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Weiss Ratings reiterated a “sell (e+)” rating on shares of Clarivate in a report on Friday, March 27th. Barclays dropped their target price on shares of Clarivate from $4.00 to $2.40 and set an “underweight” rating for the company in a research report on Wednesday, February 25th. Citigroup cut their price target on shares of Clarivate from $4.25 to $2.80 and set a “neutral” rating on the stock in a report on Wednesday, March 4th. Finally, Royal Bank Of Canada decreased their price objective on shares of Clarivate from $5.00 to $3.00 and set a “sector perform” rating for the company in a research note on Wednesday, February 25th. Five investment analysts have rated the stock with a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Reduce” and an average price target of $3.22.

Clarivate Stock Performance

The company has a debt-to-equity ratio of 0.89, a current ratio of 0.84 and a quick ratio of 0.84. The stock has a 50-day moving average price of $2.54 and a 200-day moving average price of $2.86. The firm has a market capitalization of $1.58 billion, a PE ratio of -11.79 and a beta of 1.41.

Clarivate (NYSE:CLVT) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.18 earnings per share for the quarter, beating analysts’ consensus estimates of $0.14 by $0.04. Clarivate had a positive return on equity of 8.82% and a negative net margin of 5.61%.The firm had revenue of $585.50 million during the quarter, compared to analyst estimates of $569.50 million. During the same quarter last year, the firm earned $0.14 EPS. Clarivate’s quarterly revenue was down 1.4% on a year-over-year basis. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. On average, research analysts expect that Clarivate PLC will post 0.65 EPS for the current fiscal year.

Institutional Trading of Clarivate

Institutional investors have recently added to or reduced their stakes in the stock. M&T Bank Corp bought a new stake in shares of Clarivate in the 4th quarter worth about $34,000. Essex Financial Services Inc. bought a new position in shares of Clarivate during the third quarter worth about $41,000. PharVision Advisers LLC acquired a new position in Clarivate in the third quarter worth about $45,000. Personal CFO Solutions LLC acquired a new position in Clarivate in the first quarter worth about $30,000. Finally, FreeGulliver LLC bought a new stake in Clarivate in the first quarter valued at about $30,000. 85.72% of the stock is owned by institutional investors and hedge funds.

About Clarivate

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.